Your browser doesn't support javascript.
loading
Traditional use and safety evaluation of combination Traditional Chinese Medicine in European registration: with XiaoYao Tablets as an example.
Wang, Qiong; Gao, Shenghan; Zhang, Wensheng; Zhao, Yunxia; He, Yi; Sun, Wei; Zhang, Fenglian; Yu, Tong; Zhou, Lihong; Ye, Zhengliang; Su, Jiansen; Zhang, Shunnan; Chen, Yongfa.
Afiliação
  • Wang Q; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin, PR China.
  • Gao S; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin, PR China.
  • Zhang W; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin, PR China.
  • Zhao Y; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin, PR China.
  • He Y; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin, PR China.
  • Sun W; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin, PR China.
  • Zhang F; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin, PR China.
  • Yu T; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin, PR China.
  • Zhou L; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin, PR China.
  • Ye Z; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin, PR China.
  • Su J; Tasly Healthcare Deutschland GmbH, Hannover, Germany.
  • Zhang S; State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin, PR China;, Email: zsn@tasly.com.
  • Chen Y; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China;, Email: cyf990@163.com.
Pharmazie ; 77(3): 125-130, 2022 04 10.
Article em En | MEDLINE | ID: mdl-35459442
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article